Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 58 | 2024 | 11095 | 5.190 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2024 | 3243 | 1.010 |
Why?
|
Tissue Array Analysis | 3 | 2021 | 550 | 0.960 |
Why?
|
Prostate | 8 | 2023 | 1765 | 0.940 |
Why?
|
Serine Endopeptidases | 5 | 2023 | 1021 | 0.900 |
Why?
|
Organic Anion Transporters | 1 | 2024 | 101 | 0.870 |
Why?
|
Neoplasms, Bone Tissue | 1 | 2020 | 7 | 0.730 |
Why?
|
PTEN Phosphohydrolase | 3 | 2020 | 1114 | 0.700 |
Why?
|
Squalene Monooxygenase | 2 | 2017 | 11 | 0.700 |
Why?
|
Cholesterol | 4 | 2022 | 2902 | 0.700 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2024 | 1605 | 0.670 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2020 | 175 | 0.630 |
Why?
|
Radiation, Ionizing | 1 | 2019 | 251 | 0.620 |
Why?
|
Aspirin | 3 | 2018 | 3134 | 0.600 |
Why?
|
DNA Repair | 4 | 2023 | 2044 | 0.590 |
Why?
|
Sterol O-Acyltransferase | 1 | 2017 | 28 | 0.580 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2017 | 93 | 0.570 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39078 | 0.530 |
Why?
|
Male | 72 | 2024 | 360035 | 0.520 |
Why?
|
Gangrene | 1 | 2016 | 91 | 0.520 |
Why?
|
Nonprescription Drugs | 1 | 2016 | 118 | 0.500 |
Why?
|
BRCA1 Protein | 2 | 2023 | 1146 | 0.480 |
Why?
|
Receptors, LDL | 1 | 2017 | 490 | 0.480 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2860 | 0.470 |
Why?
|
Genes, Tumor Suppressor | 1 | 2019 | 1062 | 0.460 |
Why?
|
Oncogenes | 1 | 2020 | 1223 | 0.460 |
Why?
|
Vitamin D | 2 | 2024 | 3303 | 0.420 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1087 | 0.420 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2911 | 0.400 |
Why?
|
Foot | 1 | 2016 | 574 | 0.390 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2024 | 8519 | 0.390 |
Why?
|
Metformin | 2 | 2016 | 905 | 0.370 |
Why?
|
Humans | 80 | 2024 | 760437 | 0.360 |
Why?
|
Radiation Dosage | 1 | 2019 | 1958 | 0.360 |
Why?
|
Prospective Studies | 15 | 2024 | 54339 | 0.360 |
Why?
|
Signal Transduction | 3 | 2024 | 23397 | 0.340 |
Why?
|
Genetic Variation | 3 | 2020 | 6570 | 0.320 |
Why?
|
Prescription Drugs | 1 | 2016 | 628 | 0.320 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2272 | 0.310 |
Why?
|
Aneuploidy | 2 | 2024 | 551 | 0.310 |
Why?
|
Phthalazines | 2 | 2020 | 382 | 0.300 |
Why?
|
Aged | 24 | 2024 | 168840 | 0.260 |
Why?
|
Age Factors | 1 | 2022 | 18379 | 0.260 |
Why?
|
Prognosis | 10 | 2023 | 29551 | 0.260 |
Why?
|
Dietary Supplements | 2 | 2024 | 3405 | 0.240 |
Why?
|
Prostate-Specific Antigen | 4 | 2022 | 2464 | 0.240 |
Why?
|
Chromosome Painting | 1 | 2024 | 26 | 0.240 |
Why?
|
Genomics | 1 | 2020 | 5806 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10180 | 0.230 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2023 | 30 | 0.220 |
Why?
|
Middle Aged | 23 | 2024 | 220382 | 0.220 |
Why?
|
Chromosomes, Human, Y | 1 | 2024 | 161 | 0.210 |
Why?
|
Neoplasm Metastasis | 3 | 2024 | 4903 | 0.210 |
Why?
|
Phenotype | 2 | 2020 | 16585 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
Receptors, Calcitriol | 1 | 2024 | 360 | 0.200 |
Why?
|
Prostatitis | 1 | 2022 | 102 | 0.200 |
Why?
|
BRCA2 Protein | 3 | 2022 | 799 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2023 | 313 | 0.190 |
Why?
|
Antineoplastic Agents | 3 | 2020 | 13616 | 0.190 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 5835 | 0.190 |
Why?
|
RNA Editing | 1 | 2022 | 151 | 0.190 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2022 | 112 | 0.180 |
Why?
|
Microsatellite Instability | 1 | 2024 | 715 | 0.180 |
Why?
|
Gabexate | 1 | 2020 | 12 | 0.180 |
Why?
|
Androgen Antagonists | 3 | 2024 | 1407 | 0.180 |
Why?
|
Stathmin | 1 | 2020 | 70 | 0.180 |
Why?
|
Disease Progression | 3 | 2024 | 13484 | 0.180 |
Why?
|
Piperazines | 2 | 2020 | 2519 | 0.170 |
Why?
|
p300-CBP Transcription Factors | 1 | 2021 | 150 | 0.170 |
Why?
|
Arm | 1 | 2022 | 590 | 0.170 |
Why?
|
Paraffin Embedding | 1 | 2020 | 302 | 0.170 |
Why?
|
Epidemiologic Studies | 1 | 2023 | 674 | 0.170 |
Why?
|
Androgens | 2 | 2024 | 1282 | 0.160 |
Why?
|
Guanidines | 1 | 2020 | 192 | 0.160 |
Why?
|
Esters | 1 | 2020 | 212 | 0.160 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2021 | 502 | 0.150 |
Why?
|
src-Family Kinases | 1 | 2020 | 535 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 4 | 2024 | 17854 | 0.150 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11096 | 0.150 |
Why?
|
Orchiectomy | 1 | 2020 | 463 | 0.150 |
Why?
|
Dyslexia, Acquired | 1 | 2017 | 14 | 0.140 |
Why?
|
Environment | 1 | 2023 | 1122 | 0.140 |
Why?
|
Adult | 17 | 2024 | 220781 | 0.140 |
Why?
|
Risk Factors | 10 | 2024 | 74055 | 0.140 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2020 | 653 | 0.140 |
Why?
|
Trypsinogen | 1 | 2016 | 84 | 0.140 |
Why?
|
Cryoglobulins | 1 | 2016 | 58 | 0.130 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20078 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2468 | 0.130 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20551 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3446 | 0.130 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2022 | 940 | 0.130 |
Why?
|
Cryoglobulinemia | 1 | 2016 | 84 | 0.130 |
Why?
|
Incidence | 4 | 2023 | 21322 | 0.130 |
Why?
|
Candidiasis | 1 | 2018 | 364 | 0.130 |
Why?
|
Vitamins | 1 | 2024 | 1635 | 0.130 |
Why?
|
Plasmapheresis | 1 | 2016 | 206 | 0.120 |
Why?
|
Gene Expression Profiling | 2 | 2023 | 9410 | 0.120 |
Why?
|
DNA Copy Number Variations | 2 | 2022 | 2017 | 0.120 |
Why?
|
Histocompatibility | 1 | 2016 | 317 | 0.120 |
Why?
|
Toes | 1 | 2016 | 209 | 0.120 |
Why?
|
Cohort Studies | 6 | 2024 | 41366 | 0.120 |
Why?
|
Mutation | 6 | 2024 | 30025 | 0.110 |
Why?
|
Cost of Illness | 1 | 2023 | 1931 | 0.110 |
Why?
|
Epigenomics | 1 | 2018 | 940 | 0.100 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1051 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1771 | 0.100 |
Why?
|
Population Surveillance | 1 | 2023 | 2603 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1890 | 0.100 |
Why?
|
Neonatal Screening | 1 | 2016 | 597 | 0.100 |
Why?
|
Uropathogenic Escherichia coli | 1 | 2011 | 6 | 0.100 |
Why?
|
Biopsy | 1 | 2023 | 6765 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2023 | 1847 | 0.100 |
Why?
|
Software | 2 | 2024 | 4426 | 0.100 |
Why?
|
Immunohistochemistry | 2 | 2021 | 11070 | 0.090 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58859 | 0.090 |
Why?
|
Blastocystis Infections | 1 | 2010 | 17 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9598 | 0.090 |
Why?
|
Blastocystis | 1 | 2010 | 21 | 0.090 |
Why?
|
Self Report | 1 | 2021 | 3721 | 0.090 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2010 | 64 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 1517 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6471 | 0.080 |
Why?
|
Genotype | 1 | 2024 | 12976 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2413 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2723 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1517 | 0.080 |
Why?
|
Urticaria | 1 | 2010 | 150 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5292 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5332 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3610 | 0.080 |
Why?
|
United States | 5 | 2024 | 72202 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12429 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3344 | 0.070 |
Why?
|
Escherichia coli Infections | 1 | 2011 | 523 | 0.070 |
Why?
|
Cystic Fibrosis | 1 | 2016 | 1284 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2022 | 15867 | 0.070 |
Why?
|
Exercise | 2 | 2023 | 5874 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16945 | 0.060 |
Why?
|
Neoplasms | 3 | 2024 | 22083 | 0.060 |
Why?
|
Survival Rate | 4 | 2020 | 12698 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20985 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4789 | 0.060 |
Why?
|
Urinary Tract Infections | 1 | 2011 | 806 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12653 | 0.060 |
Why?
|
Hematopoiesis | 2 | 2024 | 2049 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10075 | 0.060 |
Why?
|
Risk | 1 | 2015 | 9605 | 0.050 |
Why?
|
Residence Characteristics | 2 | 2023 | 2087 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 80430 | 0.050 |
Why?
|
Genome | 2 | 2022 | 1739 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2024 | 452 | 0.050 |
Why?
|
Marital Status | 1 | 2024 | 426 | 0.050 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2022 | 76 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11900 | 0.050 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2022 | 293 | 0.050 |
Why?
|
Life Style | 2 | 2024 | 3909 | 0.050 |
Why?
|
DNA Mismatch Repair | 1 | 2024 | 428 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 59068 | 0.050 |
Why?
|
Spain | 1 | 2022 | 489 | 0.050 |
Why?
|
Sweden | 1 | 2024 | 1378 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6330 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14002 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 320 | 0.040 |
Why?
|
Germ Cells | 1 | 2023 | 634 | 0.040 |
Why?
|
Chromosomes | 1 | 2022 | 577 | 0.040 |
Why?
|
Genetic Fitness | 1 | 2020 | 115 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2023 | 3874 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1387 | 0.040 |
Why?
|
Taxoids | 1 | 2022 | 666 | 0.040 |
Why?
|
Female | 9 | 2022 | 391875 | 0.040 |
Why?
|
Zinc | 1 | 2022 | 689 | 0.040 |
Why?
|
Glycolysis | 1 | 2022 | 832 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 709 | 0.040 |
Why?
|
Lysine | 1 | 2022 | 992 | 0.040 |
Why?
|
Organoids | 1 | 2024 | 741 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5663 | 0.040 |
Why?
|
Genetics, Population | 1 | 2022 | 939 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2020 | 694 | 0.040 |
Why?
|
beta-Glucans | 1 | 2018 | 122 | 0.040 |
Why?
|
Registries | 2 | 2024 | 8216 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3419 | 0.040 |
Why?
|
Diet, Mediterranean | 1 | 2024 | 742 | 0.030 |
Why?
|
Drug Synergism | 1 | 2020 | 1755 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 602 | 0.030 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2016 | 48 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2022 | 1077 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2020 | 870 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2020 | 64591 | 0.030 |
Why?
|
Hemianopsia | 1 | 2017 | 121 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2023 | 1850 | 0.030 |
Why?
|
Candida albicans | 1 | 2018 | 372 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2049 | 0.030 |
Why?
|
Writing | 1 | 2017 | 199 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2441 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2003 | 0.030 |
Why?
|
Prostatectomy | 1 | 2022 | 1821 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 88196 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3603 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2018 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2167 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2453 | 0.030 |
Why?
|
Reading | 1 | 2017 | 529 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6128 | 0.030 |
Why?
|
Trans-Activators | 1 | 2022 | 2858 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3590 | 0.030 |
Why?
|
Medical Oncology | 1 | 2024 | 2318 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2721 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3631 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2018 | 3088 | 0.020 |
Why?
|
Pattern Recognition, Visual | 1 | 2017 | 813 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2821 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6297 | 0.020 |
Why?
|
Paromomycin | 1 | 2010 | 14 | 0.020 |
Why?
|
HLA Antigens | 1 | 2016 | 1371 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3396 | 0.020 |
Why?
|
Risk Assessment | 2 | 2022 | 23953 | 0.020 |
Why?
|
Phosphorylation | 1 | 2021 | 8311 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2024 | 5794 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7817 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4936 | 0.020 |
Why?
|
Metronidazole | 1 | 2010 | 232 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26280 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3183 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6591 | 0.020 |
Why?
|
Virulence Factors | 1 | 2011 | 512 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13240 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10425 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15257 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9468 | 0.010 |
Why?
|
Infant | 2 | 2020 | 36183 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9462 | 0.010 |
Why?
|
Escherichia coli Proteins | 1 | 2011 | 1067 | 0.010 |
Why?
|
Cell Line | 1 | 2018 | 15598 | 0.010 |
Why?
|
Gastrointestinal Tract | 1 | 2010 | 831 | 0.010 |
Why?
|
Child, Preschool | 2 | 2020 | 42209 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10746 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 1058 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 3028 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 984 | 0.010 |
Why?
|
Mice | 2 | 2020 | 81402 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14661 | 0.010 |
Why?
|
Animals | 3 | 2020 | 168253 | 0.010 |
Why?
|
Child | 2 | 2020 | 80086 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8466 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9309 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7424 | 0.010 |
Why?
|
Brain | 1 | 2017 | 27060 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36362 | 0.010 |
Why?
|